Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Lancet ; 399(10320): 198-210, 2022 01 08.
Artigo em Inglês | MEDLINE | ID: mdl-34856192

RESUMO

Adolescence is a pivotal point in the life course, characterised by transformative physical, cognitive, and emotional growth, an openness to change, and a drive to reshape the social environment. It offers unique opportunities to adopt changes in diet and physical activity that can persist into later life. Yet pre-existing nutritional problems, including micronutrient deficiencies, food insecurity, and poor-quality diets, persist at the same time as adolescents face the rapid emergence of an obesity epidemic. Adolescent growth and nutrition has been largely overlooked in intervention and policy research. Most intervention studies have emphasised micronutrient supplementation, with few taking into account the multiple drivers of adolescent diets. This Series paper highlights that effective interventions and policies will need to cut across sectors; be supported by multifaceted and multilevel policy; and extend across education, health, food systems, social protection, and digital media. Better data standardisation and systems will be essential in coordinating and monitoring these responses. In a context of shifts in planetary ecosystems and commercial drivers, resilient food systems will need to both ensure access to healthy and affordable foods and provide the infrastructure and incentives for continuing physical activity. Intergenerational partnerships with young people will be essential in bringing about transformative change and ensuring that food policies reflect their needs and aspirations.


Assuntos
Desenvolvimento do Adolescente/fisiologia , Saúde do Adolescente , Dieta Saudável , Promoção da Saúde/organização & administração , Política Nutricional , Adolescente , Insegurança Alimentar , Saúde Global , Promoção da Saúde/métodos , Humanos , Desnutrição/epidemiologia , Desnutrição/fisiopatologia , Desnutrição/prevenção & controle , Micronutrientes/deficiência , Estado Nutricional/fisiologia , Sobrepeso/epidemiologia , Sobrepeso/fisiopatologia , Sobrepeso/prevenção & controle
2.
Obstet Gynecol ; 109(2 Pt 1): 392-401, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17267841

RESUMO

OBJECTIVE: To evaluate the relationship between fetal fibronectin and preterm birth and maternal-to-child transmission of human immunodeficiency virus (HIV) in an African population of predominantly HIV-infected women. METHODS: During a trial of second trimester and intrapartum antibiotics compared with placebo to prevent chorioamnionitis and reduce preterm birth and mother-to-child transmission of HIV, vaginal fluid was collected before antibiotics (20-24 weeks) and after treatment at 28 weeks and assayed for fetal fibronectin. Pregnancy outcomes of 2,353 women delivering liveborn singleton infants are presented. RESULTS: Positive fetal fibronectin assays (50 ng/mL or more) were detected in 4.2% and 4.9% of samples at 20-24 weeks and 28 weeks. Positive fetal fibronectin assays at 28 weeks but not at 20-24 weeks were associated with lower mean birthweight (199 g, P<.001); lower mean gestational age (2 weeks, P<.001); six-fold higher rate of preterm birth less than 32 weeks (10.8% compared with 1.9%, odds ratio 6.3, 95% confidence interval 3.2-12.3) and a two-fold higher rate of preterm birth less than 37 weeks (38.7 compared with 22.0%, odds ratio 2.3, 95% confidence interval 1.5-3.3). Also, at 28 weeks, as the fetal fibronectin values increased, each of the outcomes worsened, and every test of trend was significant. An association between elevated fetal fibronectin levels and mother-to-child transmission of HIV was present at 20 to 24 weeks but not at 28 weeks. Antibiotic treatment at 20 to 24 weeks was not associated with fetal fibronectin levels at 28 weeks. CONCLUSION: In a population of predominantly HIV- infected African women, fetal fibronectin concentrations at 28 but not at 20-24 weeks were associated with increased risk of preterm birth. The associations were stronger for early preterm birth and when fetal fibronectin levels were higher. High levels of fetal fibronectin were positively associated with mother-to-child transmission of HIV at 20 -24 but not at 28 weeks. Antibiotic treatment did not influence fetal fibronectin levels. CLINICAL TRIAL REGISTRATION: www.clinicalTrials.gov, NCT00021671 LEVEL OF EVIDENCE: I.


Assuntos
População Negra , Proteínas Fetais/metabolismo , Fibronectinas/metabolismo , Infecções por HIV/metabolismo , Complicações Infecciosas na Gravidez/metabolismo , Nascimento Prematuro/metabolismo , Adulto , África Subsaariana , Antibacterianos/uso terapêutico , Feminino , Infecções por HIV/etnologia , Infecções por HIV/transmissão , Humanos , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Placenta/patologia , Gravidez , Complicações Infecciosas na Gravidez/etnologia , Nascimento Prematuro/etnologia , Nascimento Prematuro/prevenção & controle , Vagina/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa